SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062726
Filing Date
2019-11-12
Accepted
2019-11-12 17:17:28
Documents
70
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919565d1_10q.htm 10-Q 864338
2 EXHIBIT 31.1 tm1919565d1_ex31-1.htm EX-31.1 9649
3 EXHIBIT 32.1 tm1919565d1_ex32-1.htm EX-32.1 5106
  Complete submission text file 0001104659-19-062726.txt   9173169

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20190930.xml EX-101.INS 2984875
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20190930.xsd EX-101.SCH 63390
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20190930_cal.xml EX-101.CAL 54972
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20190930_def.xml EX-101.DEF 238620
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20190930_lab.xml EX-101.LAB 435441
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20190930_pre.xml EX-101.PRE 403502
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 191210802
SIC: 2834 Pharmaceutical Preparations